Related Experiment Video
Updated: Oct 19, 2025
11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
7.8K
Programmed surface on poly(aryl-ether-ether-ketone) initiating immune mediation and fulfilling bone regeneration
Lingxia Xie1, Guomin Wang2, Yuzheng Wu1,2
1Center for Human Tissues and Organs Degeneration, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Innovation (Cambridge (Mass.))
|September 24, 2021
Summary
This study developed a novel PEEK implant coating that strategically releases anti-inflammatory (interleukin-10) and regenerative (dexamethasone) factors. This programmed release supports all bone healing phases, enhancing tissue regeneration.
Area of Science:
- Biomaterials Science
- Immunology
- Regenerative Medicine
Background:
- Immune responses are critical throughout bone healing but current biomaterials inadequately address all healing phases.
- Existing immune-regulated materials often focus only on initial inflammatory stages, neglecting later regenerative processes.
Purpose of the Study:
- To engineer a poly(aryl-ether-ether-ketone) (PEEK) implant with a programmed surface for sequential immune modulation across all bone healing stages.
- To investigate the synergistic effects of controlled release of interleukin-10 (IL-10) and dexamethasone (DEX) on macrophage polarization and osteogenesis.
Main Methods:
- Coating PEEK implants with a surface designed for sequential release of IL-10 (first week) and DEX (up to 4 weeks).
- Evaluating the immunomodulatory effects, including inflammation levels, macrophage M2 polarization, and autophagy-related factor expression.
- Assessing bone regeneration in a rat model over 8 weeks to validate the sequential immune-mediated process.
Main Results:
- The programmed coating induced a controlled initial inflammation followed by M2 macrophage polarization and enhanced autophagy.
- Synergistic IL-10 and DEX release effectively modulated the immune microenvironment, promoting osteogenesis.
- In vivo studies confirmed improved bone regeneration, validating the sequential immune-mediated strategy.
Conclusions:
- This study presents the first implant strategy utilizing both immune-mediated modulation and sequential regulation for comprehensive bone regeneration.
- The developed biomaterial offers a novel approach for tissue engineering and immunological therapeutics by addressing the dynamic nature of bone healing.
